Krithivasan Sankaranarayanan
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fatty Acids | 5 | 2024 | 204 | 1.210 |
Why?
|
| Radiation, Ionizing | 6 | 2007 | 25 | 1.210 |
Why?
|
| RNA, Ribosomal, 16S | 10 | 2024 | 324 | 0.920 |
Why?
|
| Gastrointestinal Microbiome | 6 | 2021 | 122 | 0.890 |
Why?
|
| Sequence Analysis, DNA | 10 | 2024 | 369 | 0.890 |
Why?
|
| Phylogeny | 12 | 2024 | 480 | 0.880 |
Why?
|
| DNA, Archaeal | 2 | 2014 | 21 | 0.820 |
Why?
|
| Clostridium | 1 | 2023 | 61 | 0.790 |
Why?
|
| DNA, Bacterial | 8 | 2024 | 306 | 0.720 |
Why?
|
| Microbiota | 6 | 2021 | 95 | 0.690 |
Why?
|
| Dental Calculus | 6 | 2022 | 39 | 0.670 |
Why?
|
| Bacterial Typing Techniques | 6 | 2024 | 125 | 0.600 |
Why?
|
| Base Composition | 5 | 2024 | 108 | 0.560 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2005 | 677 | 0.460 |
Why?
|
| Halorubrum | 1 | 2014 | 1 | 0.460 |
Why?
|
| Indians, North American | 2 | 2016 | 517 | 0.450 |
Why?
|
| Genetic Diseases, Inborn | 4 | 2005 | 20 | 0.450 |
Why?
|
| DNA, Ribosomal | 1 | 2014 | 159 | 0.430 |
Why?
|
| DNA, Mitochondrial | 4 | 2020 | 82 | 0.410 |
Why?
|
| Metagenome | 5 | 2021 | 52 | 0.410 |
Why?
|
| Mutation | 6 | 2011 | 848 | 0.400 |
Why?
|
| DNA Repair | 2 | 2005 | 83 | 0.390 |
Why?
|
| Genome, Human | 2 | 2018 | 73 | 0.390 |
Why?
|
| Trypanosoma cruzi | 2 | 2023 | 20 | 0.380 |
Why?
|
| Chagas Disease | 2 | 2023 | 20 | 0.380 |
Why?
|
| Bacteria | 5 | 2024 | 281 | 0.370 |
Why?
|
| Minerals | 1 | 2011 | 15 | 0.370 |
Why?
|
| Sterilization | 1 | 2011 | 8 | 0.360 |
Why?
|
| Archaea | 1 | 2011 | 54 | 0.350 |
Why?
|
| Archaeology | 6 | 2020 | 59 | 0.340 |
Why?
|
| Feces | 2 | 2021 | 109 | 0.320 |
Why?
|
| DNA, Ancient | 2 | 2019 | 33 | 0.310 |
Why?
|
| Dentin | 2 | 2018 | 12 | 0.300 |
Why?
|
| Metagenomics | 3 | 2019 | 54 | 0.300 |
Why?
|
| Humans | 25 | 2023 | 28121 | 0.300 |
Why?
|
| Ecology | 2 | 2021 | 49 | 0.300 |
Why?
|
| Radiation Protection | 1 | 2007 | 18 | 0.280 |
Why?
|
| Guidelines as Topic | 1 | 2007 | 46 | 0.280 |
Why?
|
| Environmental Exposure | 1 | 2007 | 48 | 0.270 |
Why?
|
| Methane | 2 | 2024 | 51 | 0.270 |
Why?
|
| Mammals | 1 | 2005 | 48 | 0.240 |
Why?
|
| Gene Deletion | 1 | 2005 | 118 | 0.230 |
Why?
|
| DNA Damage | 2 | 2005 | 149 | 0.230 |
Why?
|
| Methylomonas | 1 | 2024 | 3 | 0.230 |
Why?
|
| Methylocystaceae | 1 | 2024 | 4 | 0.220 |
Why?
|
| Trypanocidal Agents | 1 | 2023 | 3 | 0.220 |
Why?
|
| Nitroimidazoles | 1 | 2023 | 6 | 0.220 |
Why?
|
| Animals | 13 | 2023 | 10399 | 0.210 |
Why?
|
| Peptones | 1 | 2023 | 7 | 0.210 |
Why?
|
| Life Style | 2 | 2021 | 88 | 0.210 |
Why?
|
| California | 2 | 2014 | 67 | 0.200 |
Why?
|
| Anthropology, Physical | 2 | 2019 | 10 | 0.200 |
Why?
|
| Radiation Tolerance | 2 | 2001 | 32 | 0.200 |
Why?
|
| Industrial Development | 2 | 2020 | 11 | 0.200 |
Why?
|
| Bacterial Infections | 1 | 2022 | 56 | 0.190 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 2001 | 1 | 0.190 |
Why?
|
| Oklahoma | 4 | 2024 | 1005 | 0.190 |
Why?
|
| Base Sequence | 2 | 2014 | 584 | 0.190 |
Why?
|
| Male | 8 | 2023 | 13487 | 0.190 |
Why?
|
| Aerococcaceae | 1 | 2021 | 2 | 0.180 |
Why?
|
| Hominidae | 1 | 2021 | 11 | 0.180 |
Why?
|
| Mouth | 1 | 2021 | 31 | 0.180 |
Why?
|
| Fatty Acids, Volatile | 1 | 2021 | 15 | 0.180 |
Why?
|
| Molecular Sequence Data | 2 | 2014 | 1050 | 0.170 |
Why?
|
| Alteromonadaceae | 1 | 2020 | 2 | 0.170 |
Why?
|
| Parasites | 1 | 2020 | 11 | 0.170 |
Why?
|
| Biological Evolution | 1 | 2021 | 99 | 0.170 |
Why?
|
| Domestication | 1 | 2020 | 4 | 0.170 |
Why?
|
| Seawater | 1 | 2020 | 42 | 0.170 |
Why?
|
| Misoprostol | 1 | 1999 | 2 | 0.160 |
Why?
|
| Skeleton | 1 | 2019 | 4 | 0.160 |
Why?
|
| Cemeteries | 1 | 2019 | 4 | 0.160 |
Why?
|
| Radiation-Protective Agents | 1 | 1999 | 24 | 0.160 |
Why?
|
| Pedigree | 1 | 2019 | 155 | 0.160 |
Why?
|
| Bacteriophages | 1 | 2020 | 37 | 0.160 |
Why?
|
| Preservation, Biological | 1 | 2018 | 11 | 0.150 |
Why?
|
| Socioeconomic Factors | 1 | 2019 | 248 | 0.150 |
Why?
|
| Genomics | 1 | 2018 | 123 | 0.140 |
Why?
|
| Diet | 2 | 2015 | 231 | 0.130 |
Why?
|
| Risk Assessment | 3 | 2007 | 611 | 0.130 |
Why?
|
| Primates | 1 | 2016 | 22 | 0.130 |
Why?
|
| Saliva | 1 | 2016 | 96 | 0.130 |
Why?
|
| Evolution, Molecular | 1 | 2016 | 85 | 0.130 |
Why?
|
| Genome, Mitochondrial | 1 | 2016 | 16 | 0.130 |
Why?
|
| Gene Amplification | 1 | 2015 | 22 | 0.120 |
Why?
|
| Young Adult | 3 | 2022 | 2731 | 0.120 |
Why?
|
| Diet, Paleolithic | 1 | 2015 | 6 | 0.120 |
Why?
|
| Metabolome | 1 | 2015 | 68 | 0.120 |
Why?
|
| Agriculture | 1 | 2015 | 44 | 0.120 |
Why?
|
| Halobacteriaceae | 1 | 2014 | 3 | 0.110 |
Why?
|
| Adult | 5 | 2022 | 7757 | 0.110 |
Why?
|
| Euryarchaeota | 1 | 2014 | 26 | 0.110 |
Why?
|
| Polymerase Chain Reaction | 1 | 2014 | 268 | 0.110 |
Why?
|
| Risk Factors | 3 | 2005 | 2084 | 0.100 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 2011 | 12 | 0.090 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2011 | 13 | 0.090 |
Why?
|
| Crystallization | 1 | 2011 | 50 | 0.090 |
Why?
|
| Qatar | 2 | 2021 | 8 | 0.090 |
Why?
|
| Surface Properties | 1 | 2011 | 134 | 0.090 |
Why?
|
| Phospholipids | 2 | 2021 | 76 | 0.090 |
Why?
|
| Haplotypes | 1 | 2011 | 283 | 0.090 |
Why?
|
| Middle Aged | 3 | 2019 | 7164 | 0.090 |
Why?
|
| Mice | 4 | 2020 | 4645 | 0.090 |
Why?
|
| Aged, 80 and over | 1 | 2015 | 2021 | 0.090 |
Why?
|
| Geography | 2 | 2021 | 49 | 0.090 |
Why?
|
| Female | 5 | 2019 | 15156 | 0.080 |
Why?
|
| Genetic Variation | 1 | 2011 | 243 | 0.080 |
Why?
|
| Aged | 2 | 2019 | 5416 | 0.080 |
Why?
|
| Mitochondria | 1 | 2011 | 366 | 0.070 |
Why?
|
| Radiation Genetics | 1 | 2007 | 1 | 0.070 |
Why?
|
| International Cooperation | 1 | 2007 | 20 | 0.070 |
Why?
|
| Anti-Bacterial Agents | 2 | 2022 | 523 | 0.070 |
Why?
|
| Genome | 1 | 2005 | 57 | 0.060 |
Why?
|
| Recombination, Genetic | 1 | 2005 | 61 | 0.060 |
Why?
|
| Models, Genetic | 1 | 2005 | 125 | 0.060 |
Why?
|
| Forecasting | 1 | 2005 | 75 | 0.060 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2015 | 110 | 0.060 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2024 | 76 | 0.060 |
Why?
|
| Fresh Water | 1 | 2024 | 63 | 0.050 |
Why?
|
| Infant | 2 | 2019 | 996 | 0.050 |
Why?
|
| Child, Preschool | 2 | 2019 | 1137 | 0.050 |
Why?
|
| Soil Microbiology | 1 | 2024 | 103 | 0.050 |
Why?
|
| Gram-Positive Bacteria | 1 | 2023 | 33 | 0.050 |
Why?
|
| Oxidation-Reduction | 1 | 2024 | 362 | 0.050 |
Why?
|
| Chromosome Aberrations | 2 | 2000 | 37 | 0.050 |
Why?
|
| Violence | 1 | 2022 | 31 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2000 | 605 | 0.050 |
Why?
|
| Heart | 1 | 2023 | 223 | 0.050 |
Why?
|
| Disease Progression | 1 | 2023 | 473 | 0.050 |
Why?
|
| Gorilla gorilla | 1 | 2021 | 7 | 0.050 |
Why?
|
| Pan troglodytes | 1 | 2021 | 13 | 0.050 |
Why?
|
| Africa | 1 | 2021 | 16 | 0.050 |
Why?
|
| Dental Plaque | 1 | 2021 | 9 | 0.050 |
Why?
|
| Developed Countries | 1 | 2021 | 7 | 0.040 |
Why?
|
| Zinostatin | 1 | 2000 | 1 | 0.040 |
Why?
|
| Mutagens | 1 | 2000 | 7 | 0.040 |
Why?
|
| Nuclear Warfare | 1 | 2000 | 1 | 0.040 |
Why?
|
| Aminoglycosides | 1 | 2000 | 10 | 0.040 |
Why?
|
| Child | 2 | 2019 | 2242 | 0.040 |
Why?
|
| Japan | 1 | 2000 | 24 | 0.040 |
Why?
|
| Alleles | 1 | 2001 | 353 | 0.040 |
Why?
|
| Models, Statistical | 1 | 2001 | 128 | 0.040 |
Why?
|
| Congenital Abnormalities | 1 | 2000 | 16 | 0.040 |
Why?
|
| Ubiquinone | 1 | 2020 | 7 | 0.040 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2000 | 32 | 0.040 |
Why?
|
| Tropism | 1 | 2020 | 8 | 0.040 |
Why?
|
| Millets | 1 | 2020 | 1 | 0.040 |
Why?
|
| Quail | 1 | 2020 | 1 | 0.040 |
Why?
|
| Farmers | 1 | 2020 | 4 | 0.040 |
Why?
|
| Population Groups | 1 | 2020 | 12 | 0.040 |
Why?
|
| Bacteroides | 1 | 2020 | 15 | 0.040 |
Why?
|
| Chickens | 1 | 2020 | 61 | 0.040 |
Why?
|
| China | 1 | 2020 | 61 | 0.040 |
Why?
|
| Biofilms | 1 | 2021 | 121 | 0.040 |
Why?
|
| Adolescent | 2 | 2019 | 3123 | 0.040 |
Why?
|
| Connecticut | 1 | 2019 | 4 | 0.040 |
Why?
|
| Anthropology | 1 | 2019 | 6 | 0.040 |
Why?
|
| Emigrants and Immigrants | 1 | 2019 | 19 | 0.040 |
Why?
|
| Mice, SCID | 1 | 1999 | 61 | 0.040 |
Why?
|
| History, 19th Century | 1 | 2019 | 36 | 0.040 |
Why?
|
| Computational Biology | 1 | 2021 | 155 | 0.040 |
Why?
|
| Tooth | 1 | 2019 | 16 | 0.040 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 1999 | 103 | 0.040 |
Why?
|
| Cell Cycle | 1 | 1999 | 161 | 0.040 |
Why?
|
| Dogs | 1 | 2019 | 509 | 0.040 |
Why?
|
| Phenotype | 1 | 1999 | 679 | 0.030 |
Why?
|
| Prevotella | 1 | 2016 | 6 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 1999 | 845 | 0.030 |
Why?
|
| United States | 1 | 2022 | 2149 | 0.030 |
Why?
|
| History, 15th Century | 1 | 2016 | 13 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 2001 | 464 | 0.030 |
Why?
|
| Methanobrevibacter | 1 | 2015 | 4 | 0.030 |
Why?
|
| Treponema | 1 | 2015 | 7 | 0.030 |
Why?
|
| Classification | 1 | 2015 | 15 | 0.030 |
Why?
|
| Actinobacteria | 1 | 2015 | 11 | 0.030 |
Why?
|
| Peru | 1 | 2015 | 30 | 0.030 |
Why?
|
| Nucleic Acid Conformation | 1 | 2015 | 90 | 0.030 |
Why?
|
| Bacteroidetes | 1 | 2015 | 16 | 0.030 |
Why?
|
| Firmicutes | 1 | 2015 | 16 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 1999 | 1570 | 0.030 |
Why?
|
| Biodiversity | 1 | 2015 | 112 | 0.030 |
Why?
|
| Gene Frequency | 1 | 2011 | 185 | 0.020 |
Why?
|
| Micronuclei, Chromosome-Defective | 1 | 2000 | 1 | 0.010 |
Why?
|
| Micronucleus Tests | 1 | 2000 | 2 | 0.010 |
Why?
|
| Enediynes | 1 | 2000 | 5 | 0.010 |
Why?
|
| G2 Phase | 1 | 2000 | 15 | 0.010 |
Why?
|
| Cricetulus | 1 | 2000 | 56 | 0.010 |
Why?
|
| Cricetinae | 1 | 2000 | 130 | 0.010 |
Why?
|
| Cell Survival | 1 | 2000 | 407 | 0.010 |
Why?
|
| Cell Line | 1 | 2000 | 694 | 0.010 |
Why?
|